September 28, 2025 - 02:00

In a landscape where groundbreaking battery technologies frequently fall short of expectations, UK startup Eqonic is aiming to change the narrative. The company has developed a unique battery technology that promises to optimize energy efficiency and performance, potentially positioning it as a game changer in the industry.
Eqonic's approach focuses on creating batteries that not only enhance energy storage but also improve the overall lifecycle of battery systems. By leveraging advanced materials and innovative design, the startup aims to deliver solutions that could rival conventional battery technologies currently dominating the market.
The ambition is clear: to replicate the success of ARM, which transformed the smartphone industry with its efficient CPU designs. If Eqonic can deliver on its promises, it could pave the way for a new era of battery technology that supports the increasing demand for sustainable energy solutions. As the world moves towards greener technologies, the potential impact of Eqonic's advancements could be significant, making it a startup to watch closely.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...